Germline Genetic Variations in Methotrexate Candidate Genes Are Associated With Pharmacokinetics, Toxicity, and Outcome in Childhood Acute Lymphoblastic Leukemia

Blood - United States
doi 10.1182/blood-2013-01-480335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Germline Genomic Variants Associated With Childhood Acute Lymphoblastic Leukemia

Nature Genetics
Genetics
2009English

Methotrexate Resistance in Relation to Treatment Outcome in Childhood Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

Genetic Polymorphisms Associated With Adverse Events and Elimination of Methotrexate in Childhood Acute Lymphoblastic Leukemia and Malignant Lymphoma

Journal of Human Genetics
Genetics
2006English

Polymorphisms in Folate-Related Genes: Association With Side Effects of High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Methotrexate-Induced Side Effects Are Not Due to Differences in Pharmacokinetics in Children With Down Syndrome and Acute Lymphoblastic Leukemia

Haematologica
Hematology
2010English

Role of Polymorphisms in MTHFR and MTHFD1 Genes in the Outcome of Childhood Acute Lymphoblastic Leukemia

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2003English

Neonatal Inflammatory Markers Are Associated With Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Cancer Research
Cancer ResearchOncology
2018English

Transient Encephalopathy Following High-Dose Methotrexate Treatment in Childhood Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Childhood Acute Lymphoblastic Leukemia

Oncologist
Cancer ResearchMedicineOncology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy